Carnitron Tablet 1 mg (Granisetron Hydrochloride)

Adult dose

1. Adults 1) Chemotherapy During chemotherapy (up to one week after chemotherapy), administer granisetron 1 mg per dose twice daily, or 2 mg once daily. The initial dose should be administered within 1 hour before the start of chemotherapy, and the maximum daily dose should not exceed 9 mg. 2) Radiotherapy During radiotherapy, administer 2 mg of this medicine once daily. The initial dose should be administered within 1 hour before the start of radiotherapy, and the maximum daily dose should not exceed 9 mg. 2. Elderly patients No special dosage adjustment is necessary. 3. Patients with renal or hepatic impairment No special dosage adjustment is necessary.

This medication should not be used in patients who are allergic to it or its components. This medication may slow the movement of the intestines, so patients with symptoms of intestinal obstruction should be monitored very carefully when using this medication. Taking this medication may affect the electrical signals of the heart, so patients with heart rhythm issues or heart disease should be particularly cautious. Headache and constipation are common side effects when using this medication, most of which are mild to moderate in nature. Liver function test results may temporarily increase, but this is generally not serious. This medication can rarely cause skin rashes or serious allergic reactions, so if any unusual symptoms occur, it is important to consult a healthcare professional immediately. This medication can cause changes in mental state or serotonin syndrome, a neurological disorder, especially when taken with other serotonin-related medications, so caution is needed. There is no clear data on the effects of this medication when driving or operating machinery, but drowsiness may occur, so caution is advised. It is recommended to avoid using this medication during pregnancy or breastfeeding unless there is a specific reason, and it is safe to discontinue breastfeeding during the period of medication use. When used in children or the elderly, careful administration should be considered due to the possibility of side effects. In the event of an overdose, there is no specific antidote, so symptomatic treatment should be received, and if severe symptoms occur, immediate medical attention should be sought. This medication should be stored out of the reach of children, and care should be taken not to transfer it to another container as this may alter its quality.

• Hypersensitivity
• urticaria
• headache
• serotonin syndrome
• QT prolongation
• constipation
• increased liver aminotransferases
• rash

This medication should be stored in a tightly closed container that protects it from light, at a temperature between 1 to 30 degrees Celsius. Storing it this way will help maintain its efficacy and prevent degradation.

Appearance

White film-coated tablet with a convex triangular shape on both sides

Package unit

10 tablets (10 tablets/TPP × 1)